| Trial ID: | L1089 |
| Source ID: | NCT00400595
|
| Associated Drug: |
Mupirocin Ointment
|
| Title: |
Use of Ointments in Prevention of Catheter Related Infections in PD
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: Mupirocin ointment|DRUG: Polysporin Triple
|
| Outcome Measures: |
Primary: The primary endpoint is the time to first catheter related infection., 2Yrs | Secondary: Removal of the catheter to prevent or halt progression of a catheter related infection, 2 yrs|Hospitalizations related to catheter related infection, 2 yrs|Death due to catheter-related infection, 2 yrs|All-cause mortality, 2yrs|Technique failure (i.e. transfer to hemodialysis), 2yrs|Mupirocin or Polysporin Triple resistance, 2yrs
|
| Sponsor/Collaborators: |
Sponsor: University Health Network, Toronto
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2006-02
|
| Completion Date: |
2010-06
|
| Results First Posted: |
|
| Last Update Posted: |
2015-03-18
|
| Locations: |
Scarborough General Hospital, Toronto, Ontario, M1P 2V5, Canada|University Health Network, Toronto, Ontario, M5G 2C4, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00400595
|
